• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LIFESCAN EUROPE, A DIVISION OF CILAG GMBH INTL OT ULTRA2 METER; GLUCOSE MONITORING SYS/KIT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LIFESCAN EUROPE, A DIVISION OF CILAG GMBH INTL OT ULTRA2 METER; GLUCOSE MONITORING SYS/KIT Back to Search Results
Lot Number 4339487
Device Problem Incorrect Or Inadequate Test Results (2456)
Patient Problems Syncope (1610); Sweating (2444); Shaking/Tremors (2515)
Event Date 06/14/2018
Event Type  Injury  
Event Description
On (b)(6) 2018, the patient contacted lifescan (lfs) alleging that her onetouch ultra 2 meter was reading inaccurately high compared to feelings/normal results.The complaint was classified based on the customer care advocate (cca) documentation.The patient stated that the issue first occurred on (b)(6) 2018.The patient detailed that she tested her blood and obtained an alleged inaccurately high glucose result of 300 mg/dl on the subject meter.Meter to feelings/normal results comparisons do not meet the criteria necessary for lfs to determine the possibility of inaccuracy.The patient stated that she manages her diabetes with insulin (self-adjuster) and reported that she took an increased dose of medication in response to the alleged product issue.The patient reported that within an hour after the alleged product issue began she developed symptoms of ¿shaky, clamminess and feeling of passing out¿.She stated that she self-treated with food and drink ¿drank coca cola¿.The patient denied that she obtained a blood glucose result on another device.At the time of trouble shooting, the cca confirmed that the meter was set with the correct unit of measure at the time of testing.The test strips were stored correctly and within expiry date.The patient did not have control solution to perform a control solution test.The patient¿s products were replaced.This complaint is being reported because the patient reportedly developed symptoms that meet lfs¿ criteria for a serious injury adverse event after taking an increased dose of insulin based on alleged inaccurate high results obtained with the subject meter.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OT ULTRA2 METER
Type of Device
GLUCOSE MONITORING SYS/KIT
Manufacturer (Section D)
LIFESCAN EUROPE, A DIVISION OF CILAG GMBH INTL
gubelstrasse 34
zug 6300
SZ  6300
Manufacturer (Section G)
LIFESCAN EUROPE, A DIVISION OF CILAG GMBH INTL
gubelstrasse 34
zug 6300
SZ   6300
Manufacturer Contact
mariano chiusano
gubelstrasse 34
zug 6300
SZ   6300
MDR Report Key7662052
MDR Text Key113159180
Report Number3008382007-2018-01882
Device Sequence Number1
Product Code NBW
UDI-Device Identifier00353885008372
UDI-Public00353885008372
Combination Product (y/n)Y
Reporter Country CodeUS
PMA/PMN Number
K053529
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer
Reporter Occupation Other Caregivers
Type of Report Initial
Report Date 06/27/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Lot Number4339487
Other Device ID Number1-99SMXF
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Distributor Facility Aware Date06/27/2018
Device Age79 MO
Initial Date Manufacturer Received 06/27/2018
Initial Date FDA Received07/04/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/22/2011
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Life Threatening; Required Intervention;
Patient Age71 YR
Patient Weight68
-
-